|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0522 SEK | -2.97% |
|
+4.40% | -67.46% |
| May. 24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 07 | Chordate Medical Receives Patent Approval in the US | CI |
Chordate Medical will be granted a fourth patent in the US for the migraine treatment Ozilia. In parallel, work is underway to obtain market approval from the FDA.
| 1st Jan change | Capi. | |
|---|---|---|
| -67.46% | 2.48M | |
| +7.01% | 215B | |
| +11.01% | 187B | |
| +19.20% | 143B | |
| +30.79% | 110B | |
| +1.48% | 64.68B | |
| +13.95% | 52.96B | |
| -0.16% | 49.84B | |
| -6.20% | 38.32B | |
| +0.91% | 35.86B |
CHORDATE MEDICAL HOLDING AB 
